[1]
|
Noseworthy, J.H., Lucchinetti, C., Rodriguez, M. and Weinshenker, B.G. (2000) Multiple Sclerosis. The New England Journal of Medicine, 343, 938-952. https://doi.org/10.1056/NEJM200009283431307
|
[2]
|
Compston, A. and Coles, A. (2008) Multiple Sclerosis. The Lancet, 372, 1502-1517.
https://doi.org/10.1016/S0140-6736(08)61620-7
|
[3]
|
Polman, C.H., Reingold, S.C., Banwell, B., et al. (2011) Diagnostic Criteria for Multiple Sclerosis: 2010 Revisions to the McDonald Criteria. Annals of Neurology, 69, 292-302. https://doi.org/10.1002/ana.22366
|
[4]
|
Poser, C.M. and Brinar, V.V. (2001) Diagnostic Criteria for Multiple Sclerosis. Clinical Neurology and Neurosurgery, 103, 1-11. https://doi.org/10.1016/S0303-8467(00)00125-6
|
[5]
|
Polman, C.H., Reingold, S.C., Edan, G., et al. (2005) Diagnostic Criteria for Multiple Sclerosis: 2005 Revisions to the “McDonald Criteria”. Annals of Neurology, 58, 840-846. https://doi.org/10.1002/ana.20703
|
[6]
|
Almeida, S., Gascon, E., Tran, H., Chou, H.J., Gendron, T.F., et al. (2013) Modeling Key Pathological Features of Frontotemporal Dementia with C9ORF72 Repeat Expansion in iPSC-Derived Human Neurons. Acta Neuropathologica, 126, 385-399. https://doi.org/10.1007/s00401-013-1149-y
|
[7]
|
Song, B., Sun, G., Herszfeld, D., et al. (2012) Neural Differentiation of Patient Specific iPS Cells as a Novel Approach to Study the Pathophysiology of Multiple Sclerosis. Stem Cell Research, 8, 259-273.
https://doi.org/10.1016/j.scr.2011.12.001
|
[8]
|
Douvaras, P., Wang, J., Zimmer, M., et al. (2014) Efficient Generation of Myelinating Oligodendrocytes from Primary Progressive Multiple Sclerosis Patients by Induced Pluripotent Stem Cells. Stem Cell Reports, 3, 250-259.
https://doi.org/10.1016/j.stemcr.2014.06.012
|
[9]
|
Laterza, C., Merlini, A., De Feo, D., et al. (2013) iPSC-Derived Neural Precursors Exert a Neuroprotective Role in Immune-Mediated Demyelination via the Secretion of LIF. Nature Communications, 4, 2597.
https://doi.org/10.1038/ncomms3597
|
[10]
|
Wang, S., Bates, J., Li, X., et al. (2013) Human iPSC-Derived Oligodendrocyte Progenitor Cells Can Myelinate and Rescue a Mouse Model of Congenital Hypomyelination. Cell Stem Cell, 12, 252-264.
https://doi.org/10.1016/j.stem.2012.12.002
|
[11]
|
Takahashi, K. and Yamanaka, S. (2006) Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors. Cell, 126, 663-676. https://doi.org/10.1016/j.cell.2006.07.024
|
[12]
|
Tokumoto, Y., Ogawa, S., Nagamune, T. and Miyake, J. (2010) Comparison of Efficiency of Terminal Differentiation of Oligodendrocytes from Induced Pluripotent Stem Cells versus Embryonic Stem Cells in Vitro. Journal of Bioscience and Bioengineering, 109, 622-628. https://doi.org/10.1016/j.jbiosc.2009.11.013
|
[13]
|
Ogawa, S., Tokumoto, Y., Miyake, J. and Nagamune, T. (2011) Induction of Oligodendrocyte Differentiation from Adult Human Fibroblast-Derived Induced Pluripotent Stem Cells. In Vitro Cellular & Developmental Biology—Animal, 47, 464-469. https://doi.org/10.1007/s11626-011-9435-2
|
[14]
|
Pluchino, S., Quattrini, A., Brambilla, E., et al. (2003) Injection of Adult Neurospheres Induces Recovery in a Chronic Model of Multiple Sclerosis. Nature, 422, 688-694. https://doi.org/10.1038/nature01552
|
[15]
|
Yang, J., Yan, Y., Ciric, B., et al. (2010) Evaluation of Bone Marrow- and Brain-Derived Neural Stem Cells in Therapy of Central Nervous System Autoimmunity. The American Journal of Pathology, 177, 1989-2001.
https://doi.org/10.2353/ajpath.2010.091203
|
[16]
|
Sareen, D., O’Rourke, J.G., Meera, P., Muhammad, A.K., Grant, S., et al. (2013) Targeting RNA Foci in iPSC-Derived Motor Neurons from ALS Patients with a C9ORF72 Repeat Expansion. Science Translational Medicine, 5, 208ra149.
https://doi.org/10.1126/scitranslmed.3007529
|
[17]
|
Donnelly, C.J., Zhang, P.W., Pham, J.T., Heusler, A.R., Mistry, N.A., et al. (2013) RNA Toxicity from the ALS/FTD C9ORF72 Expansion Is Mitigated by Antisense Intervention. Neuron, 80, 415-428.
https://doi.org/10.1016/j.neuron.2013.10.015
|
[18]
|
Teuling, E., Ahmed, S., Haasdijk, E., Demmers, J., Steinmetz, M.O., Akhmanova, A., et al. (2007) Motor Neuron Disease-Associated Mutant Vesicle-Associated Membrane Protein-Associated Protein (VAP) B Recruits Wild-Type VAPs into Endoplasmic Reticulum-Derived Tubular Aggregates. Journal of Neuroscience, 27, 9801-9815.
https://doi.org/10.1523/JNEUROSCI.2661-07.2007
|
[19]
|
Plaisted, W.C., Zavala, A., Hingco, E., Tran, H., Coleman, R., Lane, T.E., Loring, J.F. and Walsh, C.M. (2016) Remyelination Is Correlated with Regulatory T Cell Induction Following Human Embryoid Body-Derived Neural Precursor Cell Transplantation in a Viral Model of Multiple Sclerosis. PLoS ONE, 11, e0157620.
https://doi.org/10.1371/journal.pone.0157620
|
[20]
|
Zhang, C., et al. (2016) Treatment of Multiple Sclerosis by Transplantation of Neural Stem Cells Derived from Induced Pluripotent Stem Cells. Science China Life Sciences, 59, 950-957. https://doi.org/10.1007/s11427-016-0114-9
|
[21]
|
Nicaise, A.M., et al. (2017) iPS-Derived Neural Progenitor Cells from PPMS Patients Reveal Defect in Myelin Injury Response. Experimental Neurology, 288, 114-121. https://doi.org/10.1016/j.expneurol.2016.11.012
|